- $147.14m
- $120.18m
- $6.02m
Helius Medical Technologies Inc expected to post a loss of 50 cents a share - Earnings Preview
Helius Medical Technologies Inc expected to post a loss of 50 cents a share - Earnings Preview
Brief: Helius Medical Announces Pons Is Now Available On The VA, FSS And GSA Advantage Contracts
Helius Medical Technologies Inc reports results for the quarter ended in March - Earnings Summary
Helius Medical Technologies Inc expected to post a loss of $3.87 a share - Earnings Preview
Brief: Helius Medical Technologies Received Notice From Nasdaq Stating Co No Longer Complies With Minimum Stockholders' Equity Requirement
Helius Medical Technologies Inc reports results for the quarter ended in December - Earnings Summary
Helius Medical Technologies Inc expected to post a loss of $3.77 a share - Earnings Preview
Brief: Helius Medical Technologies Announces Study Results Demonstrating Pons Therapy™ Helps Patients With Traumatic Brain Injury Return To Work
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius
U.S. STOCKS ON THE MOVE-Scholar Rock, Target, LL Flooring
Helius Medical rises on letter of intent for purchase of stroke therapy
Brief: Helius Medical TechnologiesReceives Letter Of Intent From The Québec Ministry Of Health And Social Services To Purchase 30 Pons® Devices
Brief: Helius Medical Technologies, Inc. Compliant With All Applicable Nasdaq Listing Criteria
Helius Medical Technologies Inc reports results for the quarter ended in June - Earnings Summary
Brief: Helius Medical Technologies Q2 EPS USD -0.06
Helius Medical Technologies Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Helius Medical Technologies Inc - Expansion Of Previously Announced Trial In Stroke From 12 To 60 Patients
Helius Medical Technologies Inc reports results for the quarter ended in March - Earnings Summary